» Articles » PMID: 32110387

Endoplasmic Reticulum Stress and Pulmonary Hypertension

Overview
Journal Pulm Circ
Publisher Wiley
Specialty Pulmonary Medicine
Date 2020 Feb 29
PMID 32110387
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Pulmonary hypertension is a fatal disease of which pulmonary vasculopathy is the main pathological feature resulting in the mean pulmonary arterial pressure higher than 25 mmHg. Moreover, pulmonary hypertension remains a tough problem with unclear molecular mechanisms. There have been dozens of studies about endoplasmic reticulum stress during the onset of pulmonary hypertension in patients, suggesting that endoplasmic reticulum stress may have a critical effect on the pathogenesis of pulmonary hypertension. The review aims to summarize the rationale to elucidate the role of endoplasmic reticulum stress in pulmonary hypertension. Started by reviewing the mechanisms responsible for the unfolded protein response following endoplasmic reticulum stress, the potential link between endoplasmic reticulum stress and pulmonary hypertension were introduced, and the contributions of endoplasmic reticulum stress to different vascular cells, mitochondria, and inflammation were described, and finally the potential therapies of attenuating endoplasmic reticulum stress for pulmonary hypertension were discussed.

Citing Articles

Irisin attenuates vascular remodeling in hypertensive mice induced by Ang II by suppressing Ca-dependent endoplasmic reticulum stress in VSMCs.

Li R, Zhuo C, Yan X, Li H, Lin L, Li L Int J Biol Sci. 2024; 20(2):680-700.

PMID: 38169582 PMC: 10758105. DOI: 10.7150/ijbs.84153.


The mechanism of programmed death and endoplasmic reticulum stress in pulmonary hypertension.

Sun Y, Liu S, Chen C, Yang S, Pei G, Lin M Cell Death Discov. 2023; 9(1):78.

PMID: 36841823 PMC: 9968278. DOI: 10.1038/s41420-023-01373-6.


Identification and immunological characterization of endoplasmic reticulum stress-related molecular subtypes in bronchopulmonary dysplasia based on machine learning.

Tao Z, Mao Y, Hu Y, Tang X, Wang J, Zeng N Front Physiol. 2023; 13:1084650.

PMID: 36699685 PMC: 9868568. DOI: 10.3389/fphys.2022.1084650.


The substitution of SERCA2 redox cysteine 674 promotes pulmonary vascular remodeling by activating IRE1/XBP1s pathway.

Yu W, Xu G, Chen H, Xiao L, Liu G, Hu P Acta Pharm Sin B. 2022; 12(5):2315-2329.

PMID: 35646520 PMC: 9136575. DOI: 10.1016/j.apsb.2021.12.025.


Histologic and proteomic remodeling of the pulmonary veins and arteries in a porcine model of chronic pulmonary venous hypertension.

Fayyaz A, Sabbah M, Dasari S, Griffiths L, DuBrock H, Wang Y Cardiovasc Res. 2022; 119(1):268-282.

PMID: 35022664 PMC: 10233294. DOI: 10.1093/cvr/cvac005.


References
1.
Schuck S, Prinz W, Thorn K, Voss C, Walter P . Membrane expansion alleviates endoplasmic reticulum stress independently of the unfolded protein response. J Cell Biol. 2009; 187(4):525-36. PMC: 2779237. DOI: 10.1083/jcb.200907074. View

2.
Bhargava A, Kumar A, Yuan N, Gewitz M, Mathew R . Monocrotaline induces interleukin-6 mRNA expression in rat lungs. Heart Dis. 2001; 1(3):126-32. View

3.
Christman B, McPherson C, Newman J, King G, Bernard G, GROVES B . An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension. N Engl J Med. 1992; 327(2):70-5. DOI: 10.1056/NEJM199207093270202. View

4.
Culley M, Chan S . Mitochondrial metabolism in pulmonary hypertension: beyond mountains there are mountains. J Clin Invest. 2018; 128(9):3704-3715. PMC: 6118596. DOI: 10.1172/JCI120847. View

5.
Dromparis P, Paulin R, Stenson T, Haromy A, Sutendra G, Michelakis E . Attenuating endoplasmic reticulum stress as a novel therapeutic strategy in pulmonary hypertension. Circulation. 2012; 127(1):115-25. DOI: 10.1161/CIRCULATIONAHA.112.133413. View